The institutional cluster is a strong bullish signal, but the 45-day reporting lag means positions were set at June 30 prices. Monitor for any insider open-market buying (Form 4) to confirm conviction, and watch for Phase 2 MOMENTUM enrollment completion (expected Q1 2027) as the next catalyst. The $300.4M cash runway removes near-term dilution risk.
How the stock moved after the report
⚠ Clustered BULLISH VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Aug 17 $4.27entry
- T+1 · 3mo ago −1.99%α −1.32% · $4.18
- T+5 · 3mo ago −3.87%α −2.68% · $4.10
- T+20 · 2mo ago −19.58%α −18.05% · $3.43
- T+60 · 7d ago −26.14%α −23.38% · $3.15
How similar events traded
Executive Summary
Eight major institutional investors, including BlackRock, State Street, and Fidelity, more than doubled their C4 Therapeutics positions in Q2 2026, adding a net $72.1M to bring aggregate holdings to $90.9M. The cluster follows a Q2 earnings beat (EPS -$0.18 vs -$0.23 consensus) and a $300.4M cash runway extending to end 2028, suggesting institutions are positioning ahead of Phase 2 MOMENTUM data expected in 2H 2027. The signal is strong but tempered by the 45-day 13F reporting lag and absence of corroborating insider open-market buying.
Key Financial Metrics
Institutional Positions
Net institutional flow: $72.0M
▲ Buyers (8)
| Institution | Action | Change | Position Value | Value Δ |
|---|---|---|---|---|
| BlackRock | DOUBLED | +285.5% | $36.9M | $31.5M |
| JPMorgan | ADD | +47.3% | $20.7M | $13.1M |
| State Street | DOUBLED | +452.4% | $9.9M | $8.9M |
| Geode | DOUBLED | +165.2% | $11.8M | $9.3M |
▼ Sellers (1)
| Institution | Action | Change | Prev Value | Value Δ |
|---|---|---|---|---|
| Walleye Capital | TRIM | -51.9% | $629.0K | -$91.2K |
Key Facts
- 8 institutions accumulated $72.1M net in Q2 2026, bringing total holdings to $90.9M
- BlackRock doubled to 7.90M shares ($36.9M), the largest position
- State Street quintupled to 2.12M shares ($9.9M), the largest % increase at +452%
- Only 1 seller (Walleye Capital trimmed -$91K), negligible selling pressure
- Q2 2026 revenue $6.6M (+2.7% YoY), EPS beat consensus by 21.7%
- Cash $300.4M extends runway to end 2028, funding Phase 2 MOMENTUM through data readout
- No insider open-market buying in the window, institutions-only signal
Financial Impact
8 institutions accumulated $72.1M in new positions while 1 reduced holdings by $91K, net institutional inflow of ~$72.0M
Risk Factors
- 45-day 13F reporting lag, positions may have been unwound since quarter-end
- No insider open-market buying to corroborate institutional conviction
- Pre-revenue biotech with binary Phase 2 data risk in 2H 2027
- Cluster dominated by mega-passive managers (BlackRock, State Street, Geode, Fidelity), may reflect index rebalancing, not active conviction
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 institutional 13F filing from SEC EDGAR.
| Document | Accession Number |
|---|---|
| INST-CLUSTER Data (Synthetic) | inst-cluster-CCCC-2026-Q2 |
Track record
19 reports on CCCC
5 of 5 bullish or bearish reports moved the stock their way by T+5. Best: +46.29% at T+60 after the Apr 9, 2026 report. 5 of 5 went positive at some point.
Filters
- Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $2.71 settles Nov 23
- Nov 12, 20264d ago 144 Neutral 2/10 Entry $2.76 settles Nov 20
- Nov 6, 202610d ago Institutional Cluster Neutral 2/10 Entry $3.10 to $2.76 ▼ −10.97% −13.56% vs SPY
- Nov 5, 202611d ago 8-K Neutral 4/10 No price data
- Nov 5, 202611d ago Press Release Neutral 5/10 Entry $2.95 to $2.77 ▼ −6.10% −9.39% vs SPY
- Sep 25, 20267w ago 8-K Neutral 4/10 Entry $2.98 to $2.95 ▼ −1.01% −0.79% vs SPY
- Sep 25, 20267w ago Press Release Neutral 4/10 Entry $2.98 to $2.95 ▼ −1.01% −0.79% vs SPY
- Aug 14, 202613w ago 144 Neutral 3/10 Entry $4.27 to $4.10 ▼ −3.87% −2.68% vs SPY
- Aug 14, 202613w ago Institutional Cluster Bullish 6/10 Viewing Entry $4.27 to $4.10 ▼ −3.87% −2.68% vs SPY
- Aug 11, 202613w ago 8-K Neutral 5/10 Entry $3.87 to $4.18 ▲ +8.01% +8.41% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers